Skip to main content
Journal cover image

Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.

Publication ,  Journal Article
Clark, PJ; Thompson, AJ; Zhu, M; Vock, DM; Zhu, Q; Ge, D; Patel, K; Harrison, SA; Urban, TJ; Naggie, S; Fellay, J; Tillmann, HL; Shianna, K ...
Published in: J Viral Hepat
May 2012

Low-density lipoprotein cholesterol (LDL-C) levels and interleukin 28B (IL28B) polymorphism are associated with sustained viral response (SVR) to peginterferon/ribavirin (pegIFN/RBV) for chronic hepatitis C (CHC) infection. IL28B has been linked with LDL-C levels using a candidate gene approach, but it is not known whether other genetic variants are associated with LDL-C, nor how these factors definitively affect SVR. We assessed genetic predictors of serum lipid and triglyceride levels in 1604 patients with genotype 1 (G1) chronic hepatitis C virus (HCV) infection by genome-wide association study and developed multivariable predictive models of SVR. IL28B polymorphisms were the only common genetic variants associated with pretreatment LDL-C level in Caucasians (rs12980275, P = 4.7 × 10(-17), poor response IL28B variants associated with lower LDL-C). The association was dependent on HCV infection, IL28B genotype was no longer associated with LDL-C in SVR patients after treatment, while the association remained significant in non-SVR patients (P < 0.001). LDL-C was significantly associated with SVR for heterozygous IL28B genotype patients (P < 0.001) but not for homozygous genotypes. SVR modelling suggested that IL28B heterozygotes with LDL-C > 130 mg/dL and HCV RNA ≤600 000 IU/mL may anticipate cure rates >80%, while the absence of these two criteria was associated with an SVR rate of <35%. IL28B polymorphisms are the only common genetic variants associated with pretreatment LDL-C in G1-HCV. LDL-C remains significantly associated with SVR for heterozygous IL28B genotype patients, where LDL-C and HCV RNA burden may identify those patients with high or low likelihood of cure with pegIFN/RBV therapy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Viral Hepat

DOI

EISSN

1365-2893

Publication Date

May 2012

Volume

19

Issue

5

Start / End Page

332 / 340

Location

England

Related Subject Headings

  • Viral Load
  • Treatment Outcome
  • Ribavirin
  • Polymorphism, Genetic
  • Middle Aged
  • Male
  • Interleukins
  • Interferons
  • Humans
  • Hepatitis C, Chronic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Clark, P. J., Thompson, A. J., Zhu, M., Vock, D. M., Zhu, Q., Ge, D., … IDEAL investigators, . (2012). Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response. J Viral Hepat, 19(5), 332–340. https://doi.org/10.1111/j.1365-2893.2011.01553.x
Clark, P. J., A. J. Thompson, M. Zhu, D. M. Vock, Q. Zhu, D. Ge, K. Patel, et al. “Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.J Viral Hepat 19, no. 5 (May 2012): 332–40. https://doi.org/10.1111/j.1365-2893.2011.01553.x.
Clark PJ, Thompson AJ, Zhu M, Vock DM, Zhu Q, Ge D, Patel K, Harrison SA, Urban TJ, Naggie S, Fellay J, Tillmann HL, Shianna K, Noviello S, Pedicone LD, Esteban R, Kwo P, Sulkowski MS, Afdhal N, Albrecht JK, Goldstein DB, McHutchison JG, Muir AJ, IDEAL investigators. Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response. J Viral Hepat. 2012 May;19(5):332–340.
Journal cover image

Published In

J Viral Hepat

DOI

EISSN

1365-2893

Publication Date

May 2012

Volume

19

Issue

5

Start / End Page

332 / 340

Location

England

Related Subject Headings

  • Viral Load
  • Treatment Outcome
  • Ribavirin
  • Polymorphism, Genetic
  • Middle Aged
  • Male
  • Interleukins
  • Interferons
  • Humans
  • Hepatitis C, Chronic